Federal Contractor Profile
The Univeristy Of Texas M.d. Anderson Cancer Center
$134M obligated·143 awards·4 agencies·21 NAICS
Federal Contracts
Showing award actions 101–150 of 178 funded award actions, most recent first.
- Contracts with positive obligations
- 143
- Funded award actions shown
- 178
- Obligations shown
- $134M
- Awarding agencies
- 4
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of September 10, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Dec 18, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00003 | 112990 | SQUIRREL MONKEY (SAIMIRI BOLIVIENSIS) EITHER GENDER, GREATER THAN 700 GRAMS, SPF IAW REQUIREMENTS NOTED IN RFQ N47 (263201600013I) | $37K |
| Nov 15, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00001 | 112990 | OWL MONKEYS (AOTUS NANCYMAAE) GENDER MIXED, IAW RFQ N45 (263201600013I) | $153K |
| Sep 27, 2019 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $8.5M |
| Sep 16, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100011 | 541712 | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS | $692K |
| Sep 13, 2019 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40119C10129 | 541714 | STUDY - MODULAR APPLICATION OF SURFACE TECHNOLOGY FOR THE GENERATION OF ANTIGEN-SPECIFIC T CELLS - BAAPMQWP#217 | $561K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $724K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100009 | 541712 | IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST | $58K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00131 | 541714 | REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER | $919K |
| Sep 9, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00132 | 541714 | CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS | $1.2M |
| Sep 7, 2019 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018319P0821 | 611310 | 06MV PHOTON | $2K |
| Aug 29, 2019 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018319P0806 | 611310 | QUALITY AUDIT PROGRAM | $600 |
| Aug 12, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100004 | 541711 | IGF::OT::IGF DETERMINATION OF DOSING REGIMENS OF ERLOTINIB IN COMBINATION WITH SULINDAC FOR PREVENTION OF COLORECTAL CANCER WHILE REDUCING AGENT TOXICITY POP 06/01/2017 - 05/31/2019 | $204K |
| Jul 15, 2019 | Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES | 75D30119C05279 | 611210 | INVASIVE MOLD DATA ACQUISITION | $151K |
| Jun 24, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00130 | 541714 | OPTIMIZATION OF DOSING REGIMENTS OF SULINDAC IN COMBINATION WITH ERLOTINIB FOR SMALL INTESTINAL AND COLON CANCER PREVENTION | $854K |
| Jun 20, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98019F00847 | 112990 | BEAGLES, MALE, 18 - 30 MONTH OF AGE; 9 - 14 KGS, IAW CONTRACT SOW (263201400013I) | $33K |
| May 15, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100008 | 541712 | IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL | $30K |
| May 14, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100011 | 541712 | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS | $790K |
| Apr 19, 2019 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40119P10151 | 112990 | BORDETELLA-FREE WEANLING BABOONS | $188K |
| Apr 1, 2019 | Department of DefenseFA8601 AFLCMC PZIO | FA860119P0316 | 622310 | RATIFICATION FOR MD ANDERSON | $8K |
| Mar 27, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100012 | 541712 | IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER | $102K |
| Oct 19, 2018 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018318P0888 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $400 |
| Sep 25, 2018 | Department of Health and Human ServicesHRSA HEADQUARTERS | HHSH250201000011C | 621991 | TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLLOD INVENTORY | $7.7M |
| Sep 21, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98018F00010 | 112990 | OWL MONKEYS (AOTUS NANCYMAAE) ADULTS, MIXED GENDER, IAW RFQ N12 (263201600013I) | $82K |
| Sep 20, 2018 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018318P0882 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $600 |
| Sep 20, 2018 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018318P0888 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $2K |
| Sep 17, 2018 | Department of Health and Human ServicesNIH NCI | 75N91018F00008 | 541711 | TARGETING THE RXR PATHWAY FOR THE PREVENTION OF TRIPLE-NEGATIVE BREAST CANCER HHSN2612015000181 TASK ORDER 9 | $778K |
| Sep 17, 2018 | Department of Health and Human ServicesNIH NCI | 75N91018F00009 | 541711 | RANK LIGAND INHIBITION - A POTENTIAL CHEMOPREVENTION STRATEGY FOR WOMEN AT HIGH GENETIC RISK OF BREAST CANCER HHSN2612015000181 TO: HHSN26100008 PP: 9/17/18 TO 3/16/2021 | $643K |
| Aug 30, 2018 | Department of Health and Human ServicesNIH NCI | HHSN26100010 | 541712 | IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT | $94K |
| Aug 14, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98018F00009 | 112990 | PER DIEM AND TESTING TO SUPPORT THE NIAID OWNED AOTUS GRISEIMEMBRA COLONY- MD ANDERSON | $110K |
| Jul 20, 2018 | Department of Health and Human ServicesNIH NCI | 75N91018F00007 | 541711 | PREVENTION OF HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) | $733K |
| Jul 6, 2018 | Department of Health and Human ServicesNIH NCI | HHSN26100010 | 541712 | IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT | $1.1M |
| May 25, 2018 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018317P0961 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $500 |
| Apr 23, 2018 | Department of Health and Human ServicesNIH NCI | HHSN26100008 | 541712 | IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL | $865K |
| Apr 10, 2018 | Department of Veterans AffairsRPO EAST (36C24E) | 36C24E18C0032 | 541715 | RPPA ANALYSIS | $23K |
| Mar 12, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | HHSN26300008 | 112990 | SQUIRREL MONKEY, BOLIVIAN, SPF, EVEN GENDER SPLIT IN ACCORDANCE WITH RFQ NDA2 (HHSN263201600013I) CAN 8338095 | $60K |
| Jan 11, 2018 | Department of Health and Human ServicesNIH NCI | HHSN26100006 | 541711 | IGF::OT::IGF TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER | $38K |
| Dec 8, 2017 | Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242) | 36C24218P0469 | 811219 | IGF::OT::IGF NJ RADIATION CALIBRATIONS | $6K |
| Oct 1, 2017 | Department of Veterans AffairsRPO EAST (36C24E) | VA24018J0407 | 541712 | RESEARCH AFFILIATE SERVICES | $62K |
| Sep 27, 2017 | Department of Veterans AffairsDEPT OF VETERANS AFFAIRS (00741) | VA74115C0021 | 541690 | IGF::OT::IGF PEER REVIEW OF RADIATION QA OPERATIONS | $354K |
| Sep 19, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100013 | 541712 | IGF::OT::IGF PILOT STUDY OF DENOSUMAB IN BRCA1/2 MUTATION CARRIERS SCHEDULED FOR RISK-REDUCING SALPINGO-OOPHERECTOMY | $524K |
| Sep 15, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100006 | 541711 | IGF::OT::IGF TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF BREAST CANCER | $681K |
| Sep 13, 2017 | Department of Veterans AffairsRPO EAST (36C24E) | VA24017C0100 | 541712 | IGF::OT::IGF GENOME SEQUENCING | $440K |
| Sep 12, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100010 | 541712 | IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT | $1.1M |
| Sep 7, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100012 | 541712 | IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER | $382K |
| Sep 1, 2017 | Department of Health and Human ServicesHRSA HEADQUARTERS | HHSH250201000011C | 621991 | TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLLOD INVENTORY | $5.3M |
| Aug 15, 2017 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018317P0961 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $600 |
| Aug 7, 2017 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018317P0930 | 611310 | IGF::OT::IGF AUDIT PROGRAM | $600 |
| Jul 18, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100009 | 541712 | IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST | $13K |
| Jun 20, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100005 | 541711 | IGF::OT::IGF TARGETED CASEIN KINASE INHIBITION AS A BREAST CANCER PREVENTION | $508K |
| Jun 6, 2017 | Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242) | VA24217P2659 | 811219 | UNAUTHORIZED COMMITMENT NJ LTD SERVICES IGF::OT::IGF | $17K |
Get Alerted Before The Univeristy Of Texas M.d. Anderson Cancer Center's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free